(Bloomberg) -- Pfizer will pay $1.25 billion upfront to license an experimental cancer drug out of China, in a deal that underscores multinational drugmakers’ growing enthusiasm for Chinese biotech ...
(Reuters) -Denmark's Novo Nordisk is partnering with biotech company Deep Apple Therapeutics in a deal worth up to $812 million to develop drugs for cardiometabolic diseases, including obesity, the ...
Drug Licensed from Sanofi Becomes First FDA-Approved Therapy for Ultra-Rare Primary Immunodeficiency
A primary immunodeficiency whose rarity means it can go undiagnosed or misdiagnosed in a patient for years now has its first drug. The FDA has approved a once-daily therapy that addresses the ...
The Drugs Technical Advisory Board (DTAB) has recommended to the national drug regulator to amend Drugs and Cosmetics Rules, 1945, to frame rules to issue licenses to pharmaceutical marketers for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results